当前位置:首页 - 行情中心 - 润贝航科(001316) - 财务分析 - 利润表

润贝航科

(001316)

  

流通市值:8.85亿  总市值:25.60亿
流通股本:2841.75万   总股本:8221.30万

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入603,578,139.32377,318,291.27162,281,359.64562,060,450.42
营业收入603,578,139.32377,318,291.27162,281,359.64562,060,450.42
二、营业总成本506,030,823.33315,039,026.26130,216,562.23472,873,365.07
营业成本454,283,919.86287,347,486.6122,490,813.77402,778,981.85
税金及附加480,581.89303,290.18131,334.19487,021.99
销售费用32,339,385.2621,010,360.9210,971,266.4334,771,513.94
管理费用25,833,537.5212,400,696.85,417,987.1722,618,493.97
研发费用6,835,198.214,411,466.422,090,233.468,094,975.29
财务费用-13,741,799.41-10,434,274.66-10,885,072.794,122,378.03
其中:利息费用173,793.0384,395.9548,241.63259,380.3
其中:利息收入10,243,813.427,444,845.43,810,999.181,953,342.12
加:公允价值变动收益-34,669.0358,116.120344,580.46
加:投资收益1,567,332.24942,250.63340,449.121,710,147.03
净敞口套期收益--0-
汇兑收益--0-
资产处置收益106,409.5290,246.035,997.73-4,067.87
资产减值损失(新)-2,834,690.37-1,792,425.85-866,130.4-7,372,972.09
信用减值损失(新)-4,308,096.74-3,183,137.21-1,176,812.6412,867,966.39
其他收益1,665,142.841,565,142.8448,523.45873,791.59
营业利润平衡项目0000
四、营业利润93,708,744.4559,959,457.5730,416,824.6797,606,530.86
加:营业外收入10,301.4710,278.353,963.8721,788.85
减:营业外支出386,686.584,878.454,876.0683,680.99
利润总额平衡项目0000
五、利润总额93,332,359.3459,964,857.4730,415,912.4897,544,638.72
减:所得税费用15,216,404.349,348,947.425,213,282.3518,453,651.63
六、净利润78,115,95550,615,910.0525,202,630.1379,090,987.09
持续经营净利润78,115,95550,615,910.0525,202,630.1379,090,987.09
归属于母公司股东的净利润78,311,086.6850,654,475.8825,221,760.9279,180,852.69
少数股东损益-195,131.68-38,565.83-19,130.79-89,865.6
(一)基本每股收益0.980.630.321.13
(二)稀释每股收益0.980.630.321.13
八、其他综合收益8,900,148.910,277,830.72-5,397,866.5719,878,924.81
归属于母公司股东的其他综合收益8,900,148.910,277,830.72-5,397,866.5719,878,924.81
九、综合收益总额87,016,103.960,893,740.7719,804,763.5698,969,911.9
归属于母公司股东的综合收益总额87,211,235.5860,932,306.619,823,894.3599,059,777.5
归属于少数股东的综合收益总额-195,131.68-38,565.83-19,130.79-89,865.6
公告日期2023-10-312023-08-302023-04-272023-04-24
审计意见(境内)标准无保留意见
TOP↑